- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03428841
Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients
The study involves assessment of hearing and visual complications along with headache after accidental dural puncture in patients receiving epidurals. Hearing loss will be assessed by clinical examination and audiometry testing, while visual complications will be assessed by clinical examination. The patients will receive standard treatment for headache in the form of drugs and if required an epidural blood patch ( injecting patient's blood in the epidural space). The course of these complications and response to treatment will be investigated over a period of time.
Audiometry results from patients with dural puncture will be compared to those of patients who also had epidurals, but without a dural puncture.
The investigators hypothesize that audiovisual complications occur more frequently in patients having accidental dural puncture with epidural needle and that the symptoms resolve with the administration of epidural blood patch.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X5
- Mount Sinai Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Parturients having accidental dural puncture during epidural placement for labour analgesia.
- Patients who give written informed consent to participate in the study.
- Dural puncture with 17G Touhy needle with/out headache
- Postural headache after 24 hours of epidural
- Labouring women undergoing vaginal or Cesarean delivery
- For the control group, patients with no dural puncture during epidural placement
Exclusion criteria:
- Patients refusing to consent
- Dural puncture with spinal needle
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with dural puncture at epidural
Patients who sustained an accidental dural puncture during the epidural procedure.
|
Other Names:
|
Patients with no dural puncture
Patients with no dural puncture during epidural procedure, to serve as a control group.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hearing loss
Time Frame: 1 month
|
Hearing loss as measured by audiometry
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severity of headache
Time Frame: 1 month
|
Pain from postdural puncture headache, rated on verbal numeric rating scale (VNRS) from 0-10, where 0 represents no pain and 10 represents worst pain.
|
1 month
|
Associated vestibular symptoms
Time Frame: 1 month
|
The presence of nausea, vomiting, vertigo, dizziness, associated with the dural puncture headache.
|
1 month
|
Associated cochlear symptoms
Time Frame: 1 month
|
The presence of hearing loss, hyperacusis or tinnitus, associated with the dural puncture headache.
|
1 month
|
Ocular symptoms
Time Frame: 1 month
|
The presence of photophobia, teichopsia, diplopia or difficulty in accommodation, associated with the dural puncture headache.
|
1 month
|
Musculoskeletal symptoms
Time Frame: 1 month
|
The presence of neck stiffness or scapular pain, associated with the dural puncture headache.
|
1 month
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Otologic Pharmaceutics, Inc.CompletedHearing Loss | Sensorineural Hearing Loss | Noise-Induced Hearing LossUnited States
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
Clinical Trials on Audiometry
-
Hospices Civils de LyonWithdrawnCochlear Prosthesis ImplantationFrance
-
HaEmek Medical Center, IsraelWithdrawnHearing Loss | Congenital HypothyroidismIsrael
-
University Hospital, LilleFondation William DemantRecruiting
-
Oticon MedicalCompletedHearing Loss, Conductive | Hearing Loss, MixedDenmark
-
Assistance Publique - Hôpitaux de ParisRecruitingMild Cognitive Impairment in Middle-aged AdultsFrance
-
Assiut UniversityNot yet recruiting
-
University of Southern DenmarkInnovation Fund Denmark; William Demant FondenRecruitingHearing Loss, Sensorineural | Hearing Impairment, SensorineuralDenmark
-
Jessa HospitalCompleted
-
University of NottinghamNational Institute for Health Research, United Kingdom; International Stem...SuspendedCancer | Hearing Loss, Sensorineural | Tinnitus, Subjective | Chemotherapeutic ToxicityUnited Kingdom